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Abstract
ADAM33, a member of the ADAM (a disintegrin and metalloprotease) gene family, is an asthma susceptibility gene origi-
nally identified by positional cloning. In the present study, we investigated the possible association of five single-nucleotide
polymorphisms (SNPs) in the ADAM33 (rs511898, rs528557, rs44707, rs597980 and rs2787094) with adult-onset asthma in
an Indian population. The study included 175 patients with mild intermittent (n = 44), mild persistent (n = 108) or moder-
ate persistent (n = 23) subgroups of asthma, and 253 nonasthmatic control individuals. SNPs were genotyped with the help
of restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR) method, and data were analysed using
chi-square test and logistic regression model. Bonferroni’s correction for multiple comparisons was applied for each hypoth-
esis. Genotypes and allele frequencies of SNPs rs511898 and rs528557 were significantly associated with adult-onset asthma
(P = 0.010-<0.001). A significant association of the homozygous mutant genotype and mutant alleles of SNPs rs2787094,
rs44707 and rs597980 with the asthma was also observed (P = 0.020-<0.001). A positive association between asthma
and haplotypes AGCCT, GGCCT, AGACT, GCAGT, GGACT, ACCCC and AGACC were also found (P = 0.036-<0.001,
OR = 2.07–8.49). Haplotypes AGCGT, GCAGC, ACAGC, ACAGT, GGAGC and GGCGT appear to protect against asthma
(P = 0.013-<0.0001, OR = 0.34–0.10). Our data suggest that ADAM33 gene polymorphisms serve as genetic risk factors for
asthma in Indian adult population.
[Tripathi P., Awasthi S., Prasad R., Husain N. and Ganesh S. 2011 Association of ADAM33 gene polymorphisms with adult-onset asthma and
its severity in an Indian adult population. J. Genet. 90, 265–273]
Introduction
Asthma is a complex disease thought to arise from inter-
actions between multiple genes and several environmental
factors (Newman-Taylor 1995; Hoffjan and Ober 2002; Illig
and Wjst 2002; Palmer and Cookson 2002; Wenzel 2006).
Asthma is an epidemic, affecting more than 155 million sub-
jects worldwide (Hoffjan and Ober 2002), and its prevalence
in India is about 2.38% (Aggarwal et al. 2006). Asthma
is defined as ‘a chronic inflammatory disorder of the con-
ducting airways and is characterized by the airway hyperre-
sponsiveness that leads to recurrent episodes of wheezing,
breathlessness, chest tightness, and coughing, particularly
at night or early morning’ (Global Initiative for Asthma
(GINA) guidelines 2005). A gene encoding a disintegrin and
∗For correspondence. E-mail: shallya@rediffmail.com.
metalloprotease (ADAM33) located on chromosome 20p13
(figure 1) was the first identified as an asthma suscep-
tibility gene by positional cloning approach in the year
2002 in a genomewide scan of a Caucasian population
(Van Eerdewegh et al. 2002). ADAM33 is a member of
the multifunctional ADAM family of genes that code for
zinc-dependent metalloproteases. The ADAM33 protein har-
bours several domains which include prometalloprotease-
like, disintegrin-like, cysteine-rich, epidermal growth factor-
like, transmembrane, and cytoplasmic domains, and many
specific functions of these domains have already been dis-
covered (Yoshinaka et al. 2002). It is highly expressed in
lung, heart, and brain of adults (Gunn et al. 2002). However,
the specific process by which ADAM33 variants could cause
asthma is unknown. One of the hypotheses suggests that
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Figure 1. Schematic representation of ADAM33 gene on chromosome 20. a) chromosome 20 showing ADAM33 gene position
20p13. b) Position of the genotyped polymorphisms (SNPs) in the ADAM33 gene in respect to the 22 exons, introns and
untranslated regions of the gene. c) Region covered by five genotyped polymorphisms (SNPs) in Mb (megabase).
ADAM33 may be involved in airway remodelling (Shapiro
and Owen 2002). The ADAM33 is indeed expressed in air-
way fibroblasts, myofibroblasts, and smooth muscle (Van
Eerdewegh et al. 2002). An association with ADAM33 vari-
ants in adult-onset asthma has been observed in several popu-
lations (Howard et al. 2003; Lind et al. 2003; Lee et al. 2004;
Raby et al. 2004; Werner et al. 2004; Blakey et al. 2005;
Hirota et al. 2006; Kedda et al. 2006; Noguchi et al. 2006;
Schedel et al. 2006; Wang et al. 2006; Sakagami et al. 2007;
Su et al. 2008; Thongngarm et al. 2008; Bijanzadeh et al.
2010; Vergara et al. 2010). However, most such studies on
ADAM33 in asthma have been carried out on Caucasian pop-
ulations; very few reports on ADAM33 SNPs in asthma are
available for Asian populations (Lee et al. 2004; Hirota et al.
2006; Noguchi et al. 2006; Wang et al. 2006; Sakagami et al.
2007; Su et al. 2008; Bijanzadeh et al. 2010). We recently
found a positive association for ADAM33 polymorphism in
the asthma affecting the children in a north Indian population
(Awasthi et al. 2011). In this study, we examined whether
such an association exists for the adult-onset asthma as
well.
Material and methods
Subjects
The study group consisted of 175 cases and 253 controls.
They were recruited for the study between August 2007 and
September 2009, at the Department of Pulmonary Medicine,
Chattrapati Shahuji Maharaj Medical University, Lucknow,
India. The study design and protocol were approved by the
institutional ethics committee and written informed consent
was obtained from subjects. The diagnosis of asthma was
based on the following inclusion criteria: (i) more than two
or three episodes of wheezing and shortness of breath during
the past year; (ii) diagnosis of asthma according to the treat-
ing physician together with the demonstration of reversible
and variable airflow obstruction by spirometry; (iii) symp-
toms; and (iv) use of medications for asthma. The diagnosis
and classification of the asthma severity was made according
to Global Initiative for Asthma (GINA) guidelines (2005).
Asthmatic patients were grouped either into one of the fol-
lowing three categories: (i) mild intermittent (n = 44); (ii)
mild persistent (n = 108); (ii) moderate persistent (n = 23)
and (iii) severe persistent (no such cases). The inclusion cri-
teria for controls were: (i) no past or present physician’s
diagnosis of asthma and other pulmonary diseases; (ii) no
history of wheezing, shortness of breath, and other symptoms
of allergic diseases such as nasal and skin symptoms; (iii)
no use of medications for asthma; and (iv) absence of first-
degree relatives with a history of asthma. All subjects includ-
ing cases and controls were personally interviewed about
their age, medical history of other diseases, demographic fea-
tures, family history of asthma, present smoking habit and
number or bidis/cigarettes smoked per day, residence near
heavy traffic/busy road with vehicular traffic and presence of
industrial area near residence.
DNA extraction and genotyping
DNA was extracted from the peripheral blood leauco-
cytes using a commercially available DNA extraction kit as
detailed in our recent study (Awasthi et al. 2011). Five SNPs
rs511898, rs2787094, rs44707, rs528557 and rs597980 of
the ADAM33 were selected for screening (accessed through
Entrez SNP database: http://www.ncbi.nlm.nih.gov/snp/).
Genotyping was done by polymerase chain reaction,
restriction fragment length polymorphisms (PCR-RFLP)
(see figure 1 in the electronic supplementary material at
http://www.ias.ernet/jgenet). PCR amplification was con-
ducted in a total volume of 15 μL with 20 pmol of each
primer. PCR conditions were as follows: initial denaturation
of 95◦C for 5 min, 40 cycles of 95◦C for 45 s, 60–65◦C for
45 s, and 72◦C for 30 s, followed by a final extension of
72◦C for 30 s. Detailed information on the location of SNPs,
PCR conditions, primer sequences, restriction enzymes, etc.
are summarized in table 1. The PCR products were then
digested overnight by restriction endonuclease at 37◦C and
were thereafter separated by electrophoresis on 10% poly-
acrylamide gel and stained with ethidium bromide. Nearly
20% of samples were regenotyped and reproducibility was
established.
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) Statistical analysis
EpiINfo 6 (Atlanta, USA, http://www.cdc.gov/epo/epi/
epiinfo.htm) and SPSS 11.5 (Chicago, USA) statistical tools
were used for the statistical analysis. Demographic char-
acteristics of patients and controls were described as fre-
quencies and percentages, whereas descriptive statistics of
patients and controls were presented as mean and standard
deviations for continuous measures. Chi square (χ2) test
was used to determine differences in genotype/allele fre-
quencies and deviation from Hardy–Weinberg equilibrium
(HWE). HWE for the cases and controls were tested sepa-
rately. Binary logistic regression was used to calculate odds
ratio (OR). Homozygous genotype for the normal allele of
each SNP in the control group was used as reference in cal-
culating OR and 95% confidence intervals (CI) as reported
(Upadhyay et al. 2009). P value was considered signifi-
cant at P < 0.05 level. P values were corrected (Pcorr)
for multiple corrections (Bonferroni correction) (He et al.
2007; Upadhyay et al. 2009). Fisher’s exact test was per-
formed to avoid type one error in subgroup analyses hav-
ing statistically low-powered sample size. Arlequin software
version 2.00 (Schneider et al. 2000) and SNPAnalyzer ver-
sion 1.0 (ISTECH, Kyungkido, Korea) were used to calculate
the distribution of haplotypes and pairwise linkage disequi-
librium between each pair of SNP loci that was evaluated
by using an expectation–maximization algorithm (Schneider
et al. 2000).
Results
We have included 175 cases of asthma of which 44 (25.1%)
had mild intermittent, 108 (61.7%) had mild persistent and
23 (13.1%) had moderate persistent subgroup of asthma.
None of the recruited patients showed severe persistent sub-
group of asthma as per the criterion of the Global Initia-
tive for Asthma (GINA) guidelines (2005). Table 2 details
the clinical features of the cases analysed. As compared to
the control group, cases had significantly higher number of
smokers (OR = 3.33, 95% CI (2.16–5.15) P = <0.0001)
and reside near industrial area (OR = 2.97, 95% CI (1.31–
6.03) P = 0.003). Among the subgroups, the mild persistent
asthmatic patients had more smokers than (OR = 2.45, 95%
CI (1.12–5.39) P = 0.014) patients suffering from moderate
persistent subgroup of asthma (OR = 1.60, 95% CI (0.51–
5.06) P = 0.364). Hospitalization rate and family history
for asthma were higher with patient suffering from moderate
persistent compared with mild persistent subgroup of asthma.
Association of ADAM33 polymorphisms with asthma compared
with controls
The genotype and allele frequencies of the ADAM33 poly-
morphisms in patients and healthy controls are provided in
table 3. To rule out any sampling bias, the HWE was cal-
culated for both cases and control groups. All five SNPs
genotyped were in HWE (P > 0.05) both in the cases and
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Table 3. Association of five genotyped ADAM33 gene polymorphisms with asthma.
Patients (n = 175) Control (n = 253)
SNPs (N) (%) (N) (%) OR (95% CI) P value
rs511898 (G>A) Genotypes
GG 25 14.3 61 24.1 1 (Reference)
GA 77 44.0 116 45.8 2.0 (1.2–3.4) 0.010∗1
AA 73 41.7 76 30.0 3.6 (2.1–6.4) <0.001
Alleles
G 127 36.3 268 53.0 1 (Reference)
A 223 63.7 238 47.0 1.98 (1.5–2.6) <0.001
rs2787094 (C>G) Genotypes
CC 17 9.7 47 18.6 1 (Reference)
CG 70 40.0 133 52.6 1.5 (0.78–2.7) 0.240
GG 88 50.3 73 28.9 3.3 (1.8–6.3) <0.001
Alleles
C 104 29.7 227 44.9 1 (Reference)
G 246 70.3 279 55.1 1.93 (1.4–2.6) <0.001
rs44707 (A>C) Genotypes
AA 31 17.7 63 24.9 1 (Reference)
AC 78 44.6 120 47.4 1.3 (0.79–2.2) 0.290
CC 66 37.7 70 27.7 1.9 (1.1–3.3) 0.020∗2
Alleles
A 140 40.0 246 48.6 1 (Reference)
C 210 60.0 260 51.4 1.42 (1.1–1.9) 0.013∗3
rs528557 (G>C) Genotypes
GG 20 11.4 159 62.8 1 (Reference)
GC 67 38.3 79 31.2 6.7 (3.8–11.9) <0.0001
CC 88 50.3 15 5.9 46.6 (22.7–95.7) <0.0001
Alleles
G 107 30.6 397 78.5 1 (Reference)
C 243 69.4 109 21.5 8.27 (6.1–11.3) <0.0001
rs597980 (C>T) Genotypes
CC 18 10.3 65 25.7 1 (Reference)
CT 61 34.9 129 51.0 1.7 (0.93–3.1) 0.083
TT 96 54.9 59 23.3 5.9 (3.2–10.9) <0.001
Alleles
C 97 27.7 259 51.2 1 (Reference)
T 253 72.3 247 48.8 2.75 (2.1–3.7) <0.001
N, number; OR, odds ratio; CI, confidence interval. *After Bonferroni correction P corr, ∗1, 0.03; ∗2, 0.06; ∗3, 0.039.
control cohorts. An increased risk for asthma was observed
for the heterozygous genotype, homozygous mutant geno-
type, and mutant allele of the SNPs rs511898 (GA, AA and A
respectively) and rs528557 (GC, CC and C respectively). An
increased risk of asthma was observed for the homozygous
mutant genotype and mutant allele of the SNPs rs2787094
(GG and G respectively), rs44707(CC and C respec-
tively) and rs597980(TT and T respectively). However, after
Bonferroni’s correction, homozygous mutant genotype of
SNP rs44707 (CC) was nonsignificant. No positive associ-
ation with asthma was observed for the heterozygous geno-
types of the SNPs rs597980, rs2787094 and rs44707 (CT, CG
and AC respectively).
ADAM33 polymorphisms in patients with and without a family
history of asthma
To test a possible difference the genotype/allele distribution
pattern in patients with a family history of asthma and those
without a family history of asthma, a ‘case only’ analysis
was performed. We found that the homozygous mutant geno-
type (TT) of SNP rs597980 was marginally associated with
patients with a family history of asthma (OR = 1.74, 95%
CI (0.91–3.32) P = 0.071). Heterozygous genotype of SNP
rs597980 and the mutant and heterozygous genotypes of rest
of the SNPs did not show an association with patients that
had a family history of asthma. (see table 1 of supplementary
material).
Association of ADAM33 polymorphisms with severity of asthma
The genotype and allele frequencies of the ADAM33 poly-
morphisms with severity subgroups of asthma are provided
in table 4. Here, we compared each subgroup of asthma
with control group separately. Results showed that indi-
viduals with homozygous mutant genotype (AA) and het-
erozygous genotype (GA) of SNP rs511898, homozygous
mutant genotype (CC) and heterozygous genotype (GC) of
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Table 5. Distribution of genotyped ADAM33 gene polymorphism’s haplotypes and its association with risk of asthma.
Haplotype
(1) (2) (3) (4) (5) Case (na = 350) Control (na = 506) OR (95% CI) P value
A G C C T 26.9 4.1 8.49 (5.01–14.49) <0.0001
G G C C T 9.5 2.4 4.26 (2.06–8.95) <0.0001
A G A C T 6.2 1.4 4.75 (1.88–12.52) 0.0001
G C A G T 5.9 2.9 2.07 (0.99–4.35) 0.0361
G G A C T 5.6 2.1 2.96 (1.27–6.97) 0.005
A G C G T 4.5 9.6 0.47 (0.25–0.88) 0.011
A C C C C 3.7 0.7 4.89 (1.45–18.12) 0.002
A G A C C 3.1 0.7 5.41 (1.37–24.94) 0.004
A C C C T 3.1 1.5 2.30 (0.80–6.76) 0.086
G C A C T 2.9 - NC
A G C G C 2.8 2.3 1.19 (0.46–3.07) 0.695
G C A G C 2.8 10.3 0.25 (0.11–0.54) <0.0001
G C C G C 2.8 4.1 0.67 (0.28–1.56) 0.317
A C A G C 2.8 8.2 0.33 (0.15–0.71) 0.002
A G C C C 2.7 1.5 1.80 (0.63–5.18) 0.224
A C A G T 1.9 5.3 0.34 (0.12–0.87) 0.013
A G A G T 1.9 2.3 0.86 (0.28–2.54) 0.768
A C A C C 1.6 1.2 1.32 (0.35–4.93) 0.645
G G A C C 1.5 0.6 2.66 (0.55–14.12) 0.165
G G A G C 1.3 4.3 0.28 (0.08–0.86) 0.013
A C A C T 1.3 0.8 1.59 (0.33–7.59) 0.511
G G C C C 1.2 1.6 0.79 (0.20–2.91) 0.698
G G C G T 1.0 8.8 0.10 (0.02–0.33) <0.0001
n, Number; OR, odds ratio; CI, confidence interval. aTotal number of chromosomes; NC, not calculated. (1) rs511898 (G>A); (2) rs2787094
(C>G); (3) rs44707 (A>C); (4) rs528557 (G>C); (5) rs597980 (C>T). ∗Mutant alleles are in bold font.
SNP rs528557 and homozygous mutant genotype (CC) of
SNP rs597980 were at risk for mild intermittent subgroup of
asthma. SNPs rs2787094 and rs44707 were not significantly
associated with mild intermittent subgroup of asthma.
Individuals with homozygous mutant genotypes of SNP
rs511898 and rs2787094 (AA and GG respectively), het-
erozygous and homozygous mutant genotypes of SNPs
rs528557 and rs597980 (GC/CC and CT/TT respectively)
were at increased risk for mild persistent subgroup of asthma.
However, after Bonferroni’s correction, the heterozygous
genotype (CT) of SNP rs597980 failed to show any asso-
ciation with the mild persistent subgroup of asthma. Geno-
types of SNP rs44707 did not show an association with mild
persistent subgroup of asthma. Individuals with homozygous
mutant genotype of SNPs rs511898, rs2787094, rs44707 and
rs597980 (AA, GG, CC and TT respectively) and heterozy-
gous and homozygous mutant genotypes of SNP rs528557
(GC and CC) were at risk for moderate persistent subgroup
of asthma. Nevertheless, after applying Bonferroni’s correc-
tion, the homozygous mutant genotypes of SNPs rs2787094
and rs44707 were found to be ‘nonsignificant’.
Significant results were observed with subgroups of
asthma. However, results were conflicting to find out its asso-
ciation, based on increasing severity of asthma as per the cri-
terion of the Global Initiative for Asthma (GINA) guidelines
(2005). Mutant genotypes of SNPs rs511898, rs2787094, and
rs597980 (AA, GG and TT respectively) were found to be
more likely significantly associated with mild persistent sub-
group of asthma as compared with moderate persistent. Like-
wise, heterozygous genotype of SNP rs597980 was highly
associated with mild intermittent as compared to its associa-
tions with mild persistent subgroup and moderate persistent
subgroups of asthma. This indicates that association was not
related to increasing severity of asthma.
Association of ADAM33 haplotypes with risk of asthma
We constructed the ADAM33 haplotypes of cases and con-
trols and evaluated their possible role in asthma. Haplotypes
with frequencies >1% were selected for analysis (table 5).
The frequency of haplotypes AGCCT, GGCCT, AGACT,
GCAGT, GGACT, ACCCC and AGACC were significantly
higher in cases than in controls (P = 0.036- <0.001, OR =
2.07–8.49). In contrast, frequency of haplotypes AGCGT,
GCAGC, ACAGC, ACAGT, GGAGC and GGCGT was
more common in the control group than in the case group
(P = 0.013- <0.0001, OR = 0.34–0.10). We have also evalu-
ated the pairwise linkage disequilibrium (LD) between each
pair of SNP loci. Both for cases and controls, the LD mea-
sure D′ was high for all but one SNP tested in cases, and for
two SNPs in the control group (Yates’s corrected P value <
0.05 and |D′| = 0) (see table 2 in electronic supplementary
material).
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Discussion
In this case–control study, we analysed the association of five
SNPs of spanning ADAM33 and their haplotypes with the
adult-onset asthma and its severity in an Indian population.
We found that the homozygous mutant, heterozygous geno-
types and allele frequencies of SNPs rs511898 and rs528557
located within the ADAM33 gene were significantly asso-
ciated with susceptibility to asthma. Further homozygous
mutant genotypes and mutant alleles of SNPs rs2787094 and
rs597980 also showed significant association with asthma.
Since multiple SNPs may act together and increase the risk
of asthma, haplotypes for five SNPs were constructed and
their frequency were compared among cases and controls.
Our haplotype analyses suggest that the haplotypes AGCCT,
GGCCT, AGACT, GCAGT, GGACT, might serve as risk
factors for asthma in the Indian population. Conversely, hap-
lotypes AGCGT, GCAGC, ACAGC, ACAGT, GGAGC and
GGCGT might serve as protective factors for the disease.
Our results extend the previous findings on possible role of
ADAM33 in genetic susceptibility to asthma in diverse pop-
ulations (Howard et al. 2003; Werner et al. 2004; Hirota
et al. 2006; Noguchi et al. 2006; Su et al. 2008; Thongn-
garm et al. 2008). Lack of association for ADAM33 gene in
asthma have also been reported in populations from Korea
(Lee et al. 2004), Australia (Kedda et al. 2006), P. R. China
(Wang et al. 2006), Germany (Schedel et al. 2006), and the
Caribbean coast of Colombia (Vergara et al. 2010). Intrigu-
ingly, the sets of SNPs have also shown significant associa-
tion with the child-onset asthma in our recent study (Awasthi
et al. 2011) suggesting a role for this gene both in childhood-
onset and adulthood-onset asthma in the Indian population.
Possible role for ADAM33 gene in the childhood asthma have
been excluded in an Mexican population (Lind et al. 2003)
and in a Caucasian population of North America (Raby et al.
2004). Nonetheless, meta-analyses encompassing data from
several studies reveal a positive association for the ADAM33
SNPs rs511898 and rs1713853 with asthma. SNP rs1713853
was not tested in the present study (Blakey et al. 2005). Con-
versely, there seem to be a population specific variation with
regard to the SNP(s) that show association with asthma.
However, SNP rs528557 was shown to be associated
with asthma in a UK-based Caucasian population (Van
Eerdewegh et al. 2002), a family-based study in Germans
(Werner et al. 2004), in African-Americans, US whites,
Hispanic (Howard et al. 2003), Japanese (Hirota et al.
2006), and in Thai population (Thongngarm et al. 2008),
besides the present study on an Indian population. Simi-
larly, SNP rs511898 was shown to associate with asthma in
a UK and German populations (Van Eerdewegh et al. 2002;
Werner et al. 2004) while the association of SNP rs597980
was restricted to the German families only (Werner et al.
2004). Intriguingly, SNP rs44707 was found to associate
with asthma in diverse set of populations; US/UK combined,
UK-only, Dutch white and in adult Chinese Han popula-
tions (Van Eerdewegh et al. 2002; Howard et al. 2003; Su
et al. 2008). Thus, the present study adds to the growing
list of population studies where the ADAM33 SNPs seems
to play a role in the susceptibility to asthma. These studies
also highlight the fact that no single SNP is associated with
asthma in all the populations studied. This may be due to the
compound effects of multiple alleles, multiple genes and
environmental factors since asthma is a multi-factorial dis-
order. For example, the effect of a given SNP could be
restricted to an ethnic group or a population; thus, there
may be genetic differences among subtypes of asthma,
such as pediatric, adult, allergic/nonallergic. Secondly, this
could be due to the difference in the exposure to allergens,
which could vary from one geographical region to the other
and their interactions with the genetic factor(s) could vary
(Postma and Howard 2004; Vercelli 2004). Thirdly, the link-
age disequilibrium patterns that exist between the identi-
fied SNP and the undetected causative defect in the gene
could differ from one population to the other. Thus through
understanding the genetic factors and their interactions with
the environmental factors for each population would aid in
developing effective predictive markers for the prevention
and/or management of multifactorial diseases like asthma.
In summary, our results suggest an association between the
ADAM33 gene polymorphisms and asthma in the Indian pop-
ulation studied. Functional studies on the ADAM33 SNPs and
other sequence variants might uncover the molecular basis of
susceptibility to asthma.
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